NCT07614399

Brief Summary

Dear Sir or Madam, You have been invited to participate in a clinical study whose aim is to compare the effectiveness of two different approaches to the treatment of cerebrospinal fluid (CSF) pseudomeningocele - conservative management and interventional treatment (surgical or drainage procedures). CSF pseudomeningocele is a complication that may occur after brain surgery and is characterized by an accumulation of cerebrospinal fluid beneath the skin. At present, there is no clear consensus regarding the optimal treatment approach. How the study will be conducted After enrollment in the study, you will be randomly assigned (by chance) to one of two groups: Conservative management: no surgical intervention, regular follow-up, and wound care. Interventional treatment: simple aspiration/puncture, insertion of a lumbar drain, or reoperation. During the study, you will be followed for a period of 1 year. Follow-up examinations will include clinical assessment and brain imaging (CT or MRI) at 4 months and 12 months after enrollment. Risks associated with the interventional group Simple cyst aspiration/puncture: infection, bleeding into the pseudomeningocele. Lumbar drainage: infection, meningitis, bleeding at the insertion site, cerebrospinal fluid leakage, nerve root irritation, headaches. Reoperation: bleeding, infection, complications related to general anesthesia. Expected duration of participation in the study 12 months Expected total number of participants enrolled in the study 20 participants Benefit of the study The aim of the study is to compare the effect of surgical intervention with conservative management. Compensation for participation Participation in this study is not associated with any financial compensation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
52mo left

Started Nov 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Nov 2025Nov 2030

Study Start

First participant enrolled

November 1, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 15, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 29, 2026

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2029

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2030

Last Updated

May 29, 2026

Status Verified

May 1, 2026

Enrollment Period

4 years

First QC Date

May 15, 2026

Last Update Submit

May 22, 2026

Conditions

Keywords

Cerebrospinal Fluid LeakPostoperative ComplicationsNeurosurgery

Outcome Measures

Primary Outcomes (1)

  • CSF Leakage or Tension pseudomeningocoele

    New-onset wound CSF leakage requiring revision surgery, or pseudomeningocele associated with severe headaches not responsive to analgesics.

    12 months

Secondary Outcomes (4)

  • Infection

    12 months

  • Glasgow Outcome Scale Extended (GOSE)

    12 months

  • Absorption of the Pseudomeningocoele

    12 months

  • Pain

    12 months

Study Arms (2)

Conservative

NO INTERVENTION

Patients managed without surgical procedures, except for skin sutures.

Interventional

EXPERIMENTAL

Patients undergoing local treatment - lumbar drainage insertion, simple wound puncture, fibrin glue or any combination.

Procedure: Lumbar DrainageProcedure: Pseudomeningocele PunctureProcedure: Puncture with Fibrin Glue ApplicationProcedure: Revision

Interventions

Insertion of Lumbar drain

Interventional

after aspiration of the CSF a fibrin glue is injected into the pseudomeningocele

Interventional
RevisionPROCEDURE

Revision surgery in order to prevent future pseudomeninogocele formation

Interventional

aspiration of the CSF fluid with injection

Interventional

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pseudomeningocele after elective intracranial surgery
  • Willing and able to give informed consent
  • No prior cranial or spinal surgical intervention
  • Pseudomeningocele Palpation Scale (PPS) II-IV, no severe pain of the PMC (VAS 7-10) - Tension MK

You may not qualify if:

  • PMC following emergency or trauma surgery
  • Known or suspected infection at the PMC site at recruitment
  • Severe comorbidities preventing participation (e.g. terminal illness, organ failure)
  • Conditions requiring urgent unrelated surgical intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Military University Hospital Prague

Prague, Prague, 16000, Czechia

RECRUITING

MeSH Terms

Conditions

Cerebrospinal Fluid OtorrheaIntracranial HypertensionCerebrospinal Fluid LeakPostoperative Complications

Interventions

PuncturesSecond-Look Surgery

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemSigns and SymptomsPathological Conditions, Signs and SymptomsWounds and InjuriesBrain DiseasesCentral Nervous System DiseasesPathologic Processes

Intervention Hierarchy (Ancestors)

TherapeuticsSurgical Procedures, Operative

Central Study Contacts

Norbert Svoboda, MD, PhD, FEBNS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Neurosurgeon, Consultant, Head of Department of Cranial Surgery.

Study Record Dates

First Submitted

May 15, 2026

First Posted

May 29, 2026

Study Start

November 1, 2025

Primary Completion (Estimated)

November 1, 2029

Study Completion (Estimated)

November 1, 2030

Last Updated

May 29, 2026

Record last verified: 2026-05

Locations